No photo of Michael X Repka

View Scopus Profile

Michael X Repka

Professor

1983 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michael X Repka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study

on behalf of the G-ROP Study Group, Jul 1 2020, In : Journal of Perinatology. 40, 7, p. 1100-1108 9 p.

Research output: Contribution to journal › Article

    • Incidence and Management of Glaucoma or Glaucoma Suspect in the First Year after Pediatric Lensectomy

    Freedman, S. F., Kraker, R. T., Repka, M. X., Wallace, D. K., De Alba Campomanes, A., Yanovitch, T. L., Orge, F. H. & Gearinger, M. D., Jan 2020, In : JAMA ophthalmology. 138, 1, p. 71-75 5 p.

    Research output: Contribution to journal › Article

    • Lower foetal haemoglobin levels at 31- and 34-weeks post menstrual age is associated with the development of retinopathy of prematurity: PacIFiHER Report No. 1 PacIFiHER Study Group (Preterm Infants and Fetal Haemoglobin in ROP)

    Jiramongkolchai, K., Repka, M. X., Tian, J., Aucott, S. W., Shepard, J., Collins, M., Kraus, C., Clemens, J., Feller, M., Burd, I., Roizenblatt, M., Goldberg, M. F., Arevalo, J. F., Gehlbach, P. & Handa, J. T., 2020, (Accepted/In press) In : Eye (Basingstoke).

    Research output: Contribution to journal › Article

    • Parent and Teacher Perspectives on Factors Decreasing Participation in School-Based Vision Programs

    Vongsachang, H., Friedman, D. S., Inns, A., Kretz, A. M., Mukherjee, M. R., Callan, J., Wahl, M., Repka, M. X. & Collins, M. E., May 3 2020, In : Ophthalmic Epidemiology. 27, 3, p. 226-236 11 p.

    Research output: Contribution to journal › Article

    • Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity

    Crouch, E. R., Kraker, R. T., Wallace, D. K., Holmes, J. M., Repka, M. X., Collinge, J. E., Bremer, D. L., Gray, M. E., Smith, H. A. & Steinkuller, P. G., Jan 2020, In : JAMA ophthalmology. 138, 1, p. 14-20 7 p.

    Research output: Contribution to journal › Article